Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | SMYD3 | Q9H7B4 | 8/20 | 0.42 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | JAK3 | P52333 | 1/20 | 0.40 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.40 |
| ▸ | AHR | P35869 | 1/20 | 0.40 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.39 |
| ▸ | EIF2AK2 | P19525 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14815695 | 0.85 | MAOB (0.53) | MAOBSMYD3ROCK2MAOAKCNH2 | |
| SCHEMBL14815914 | 0.74 | MAOB (0.52) | MAOBGAASMYD3 | |
| SCHEMBL31722184 | 0.74 | MAOA (0.56) | MAOBROCK2MAOAKCNH2CRBN | |
| SCHEMBL14815951 | 0.74 | MAOA (0.56) | MAOBROCK2MAOAKCNH2CRBN | |
| SCHEMBL27691373 | 0.74 | MAOB (0.50) | MAOBGAASMYD3AHREIF2AK2 | |
| SCHEMBL7404515 | 0.72 | MAOB (0.65) | MAOBMAOAKCNH2AHRCRBN | |
| SCHEMBL689457 | 0.72 | MAOB (0.62) | MAOBGAAMAOAKCNH2AHR | |
| SCHEMBL8092883 | 0.72 | MAOB (0.47) | MAOBSMYD3ROCK2KCNH2 | |
| SCHEMBL11600967 | 0.72 | MAOA (0.60) | MAOBROCK2MAOAKCNH2CRBN | |
| SCHEMBL31718406 | 0.72 | MAOA (0.60) | MAOBROCK2MAOAKCNH2CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2760856-B1 | SELECTIVE NR2B ANTAGONISTS | BRISTOL MYERS SQUIBB CO (US) | 2016-09-14 | — | — | EP | disclosed |
| WO-2013049119-A1 | SELECTIVE NR2B ANTAGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-04-04 | — | — | WO | disclosed |